These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
369 related items for PubMed ID: 28756805
21. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. Shah DN, Aitken SL, Barragan LF, Bozorgui S, Goddu S, Navarro ME, Xie Y, DuPont HL, Garey KW. J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056 [Abstract] [Full Text] [Related]
22. Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland. Robertson C, Pan J, Kavanagh K, Ford I, McCowan C, Bennie M, Marwick C, Leanord A. J Hosp Infect; 2020 Nov; 106(3):554-561. PubMed ID: 32717202 [Abstract] [Full Text] [Related]
24. Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: an analysis of hospital episode statistics in four European countries. Eckmann C, Wasserman M, Latif F, Roberts G, Beriot-Mathiot A. Eur J Health Econ; 2013 Oct; 14(5):835-46. PubMed ID: 23797490 [Abstract] [Full Text] [Related]
25. Assessing the burden of Clostridium difficile infections for hospitals. Hebbinckuys E, Marissal JP, Preda C, Leclercq V. J Hosp Infect; 2018 Jan; 98(1):29-35. PubMed ID: 28890287 [Abstract] [Full Text] [Related]
26. The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting. Bond SE, Boutlis CS, Yeo WW, Pratt WAB, Orr ME, Miyakis S. J Hosp Infect; 2017 Apr; 95(4):387-393. PubMed ID: 28131640 [Abstract] [Full Text] [Related]
27. The burden of Clostridium difficile in surgical patients in the United States. Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. Surg Infect (Larchmt); 2007 Dec; 8(6):557-66. PubMed ID: 18171114 [Abstract] [Full Text] [Related]
28. Clostridium difficile colitis in patients undergoing lumbar spine surgery. Skovrlj B, Guzman JZ, Silvestre J, Al Maaieh M, Qureshi SA. Spine (Phila Pa 1976); 2014 Sep 01; 39(19):E1167-73. PubMed ID: 24979408 [Abstract] [Full Text] [Related]
29. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. BMC Infect Dis; 2016 Aug 25; 16(1):447. PubMed ID: 27562241 [Abstract] [Full Text] [Related]
30. The economic burden of Clostridium difficile. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY. Clin Microbiol Infect; 2012 Mar 25; 18(3):282-9. PubMed ID: 21668576 [Abstract] [Full Text] [Related]
31. A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study. Touat M, Opatowski M, Brun-Buisson C, Cosker K, Guillemot D, Salomon J, Tuppin P, de Lagasnerie G, Watier L. Appl Health Econ Health Policy; 2019 Jun 25; 17(3):381-389. PubMed ID: 30506456 [Abstract] [Full Text] [Related]
32. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care. Olanipekun TO, Salemi JL, Mejia de Grubb MC, Gonzalez SJ, Zoorob RJ. Diabetes Res Clin Pract; 2016 Jun 25; 116():68-79. PubMed ID: 27321318 [Abstract] [Full Text] [Related]
33. Excess length of hospital stay, mortality and cost attributable to Clostridioides (Clostridium) difficile infection and recurrence: a nationwide analysis in Japan. Kimura T, Stanhope S, Sugitani T. Epidemiol Infect; 2020 Mar 02; 148():e65. PubMed ID: 32115019 [Abstract] [Full Text] [Related]
34. Healthcare burden of recurrent Clostridioides difficile infection in Japan: A retrospective database study. Kunishima H, Ito K, Laurent T, Abe M. J Infect Chemother; 2018 Nov 02; 24(11):892-901. PubMed ID: 30190105 [Abstract] [Full Text] [Related]
35. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011. Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. Am J Infect Control; 2015 Nov 02; 43(11):1148-53. PubMed ID: 26521932 [Abstract] [Full Text] [Related]
36. Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals. Delgado A, Reveles IA, Cabello FT, Reveles KR. BMC Infect Dis; 2017 Jun 23; 17(1):448. PubMed ID: 28645266 [Abstract] [Full Text] [Related]
37. Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study. Yu H, Baser O, Wang L. BMC Geriatr; 2016 Nov 25; 16(1):193. PubMed ID: 27884118 [Abstract] [Full Text] [Related]
38. Analysis of Clostridium difficile infections after cardiac surgery: epidemiologic and economic implications from national data. Flagg A, Koch CG, Schiltz N, Chandran Pillai A, Gordon SM, Pettersson GB, Soltesz EG. J Thorac Cardiovasc Surg; 2014 Nov 25; 148(5):2404-9. PubMed ID: 24823282 [Abstract] [Full Text] [Related]
39. Burden of Clostridium difficile infection on hospital readmissions and its potential impact under the Hospital Readmission Reduction Program. Chopra T, Neelakanta A, Dombecki C, Awali RA, Sharma S, Kaye KS, Patel P. Am J Infect Control; 2015 Apr 01; 43(4):314-7. PubMed ID: 25838133 [Abstract] [Full Text] [Related]